159 related articles for article (PubMed ID: 27487087)
1. Chemistry of Renieramycins. 15. Synthesis of 22-O-Ester Derivatives of Jorunnamycin A and Their Cytotoxicity against Non-Small-Cell Lung Cancer Cells.
Sirimangkalakitti N; Chamni S; Charupant K; Chanvorachote P; Mori N; Saito N; Suwanborirux K
J Nat Prod; 2016 Aug; 79(8):2089-93. PubMed ID: 27487087
[TBL] [Abstract][Full Text] [Related]
2. Chemistry of Renieramycins. 17. A New Generation of Renieramycins: Hydroquinone 5-O-Monoester Analogues of Renieramycin M as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells.
Chamni S; Sirimangkalakitti N; Chanvorachote P; Saito N; Suwanborirux K
J Nat Prod; 2017 May; 80(5):1541-1547. PubMed ID: 28459574
[TBL] [Abstract][Full Text] [Related]
3. Chemistry of Renieramycins. Part 19: Semi-Syntheses of 22-
Chamni S; Sirimangkalakitti N; Chanvorachote P; Suwanborirux K; Saito N
Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32785022
[TBL] [Abstract][Full Text] [Related]
4. Chemistry of renieramycins. Part 5. Structure elucidation of renieramycin-type derivatives O, Q, R, and S from thai marine sponge Xestospongia species pretreated with potassium cyanide.
Amnuoypol S; Suwanborirux K; Pummangura S; Kubo A; Tanaka C; Saito N
J Nat Prod; 2004 Jun; 67(6):1023-8. PubMed ID: 15217287
[TBL] [Abstract][Full Text] [Related]
5. Light-Mediated Transformation of Renieramycins and Semisynthesis of 4'-Pyridinecarbonyl-Substituted Renieramycin-Type Derivatives as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells.
Sinsook S; Buaban K; Iksen I; Petsri K; Innets B; Chansriniyom C; Suwanborirux K; Yokoya M; Saito N; Pongrakhananon V; Chanvorachote P; Chamni S
Mar Drugs; 2023 Jul; 21(7):. PubMed ID: 37504931
[TBL] [Abstract][Full Text] [Related]
6. Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines.
Buaban K; Innets B; Petsri K; Sinsook S; Chanvorachote P; Chansriniyom C; Suwanborirux K; Yokoya M; Saito N; Chamni S
Sci Rep; 2023 Dec; 13(1):21485. PubMed ID: 38057385
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric Synthesis and Cytotoxicity Evaluation of Right-Half Models of Antitumor Renieramycin Marine Natural Products.
Matsubara T; Yokoya M; Sirimangkalakitti N; Saito N
Mar Drugs; 2018 Dec; 17(1):. PubMed ID: 30577460
[TBL] [Abstract][Full Text] [Related]
8. Chemistry of renieramycins. Part 8: synthesis and cytotoxicity evaluation of renieramycin M-jorunnamycin A analogues.
Charupant K; Daikuhara N; Saito E; Amnuoypol S; Suwanborirux K; Owa T; Saito N
Bioorg Med Chem; 2009 Jul; 17(13):4548-58. PubMed ID: 19457672
[TBL] [Abstract][Full Text] [Related]
9. Chemistry of renieramycins. Part 3.(1) isolation and structure of stabilized renieramycin type derivatives possessing antitumor activity from Thai sponge Xestospongia species, pretreated with potassium cyanide.
Suwanborirux K; Amnuoypol S; Plubrukarn A; Pummangura S; Kubo A; Tanaka C; Saito N
J Nat Prod; 2003 Nov; 66(11):1441-6. PubMed ID: 14640515
[TBL] [Abstract][Full Text] [Related]
10. Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.
Mohler ML; Kang GS; Hong SS; Patil R; Kirichenko OV; Li W; Rakov IM; Geisert EE; Miller DD
J Med Chem; 2006 Sep; 49(19):5845-8. PubMed ID: 16970409
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric Total Syntheses of (-)-Fennebricin A, (-)-Renieramycin J, (-)-Renieramycin G, (-)-Renieramycin M, and (-)- Jorunnamycin A via C-H Activation.
Zheng Y; Li XD; Sheng PZ; Yang HD; Wei K; Yang YR
Org Lett; 2020 Jun; 22(11):4489-4493. PubMed ID: 32437173
[TBL] [Abstract][Full Text] [Related]
12. 5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis.
Chantarawong W; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30754694
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
[TBL] [Abstract][Full Text] [Related]
14. Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells.
Sumkhemthong S; Chamni S; Ecoy GU; Taweecheep P; Suwanborirux K; Prompetchara E; Chanvorachote P; Chaotham C
Mar Drugs; 2021 May; 19(5):. PubMed ID: 34063628
[TBL] [Abstract][Full Text] [Related]
15. Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge
Iksen I; Sinsook S; Wattanathamsan O; Buaban K; Chamni S; Pongrakhananon V
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558080
[TBL] [Abstract][Full Text] [Related]
16. Renieramycin J, a highly cytotoxic tetrahydroisoquinoline alkaloid, from a marine sponge Neopetrosia sp.
Oku N; Matsunaga S; van Soest RW; Fusetani N
J Nat Prod; 2003 Aug; 66(8):1136-9. PubMed ID: 12932144
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic evaluation of some cribrostatin-ecteinascidin analogues.
Wright BJ; Chan C; Danishefsky SJ
J Nat Prod; 2008 Mar; 71(3):409-14. PubMed ID: 18278868
[TBL] [Abstract][Full Text] [Related]
18. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
[TBL] [Abstract][Full Text] [Related]
19. Chemistry of ecteinascidins. Part 3: preparation of 2'-N-acyl derivatives of ecteinascidin 770 and evaluation of cytotoxicity.
Saktrakulkla P; Toriumi S; Tsujimoto M; Patarapanich C; Suwanborirux K; Saito N
Bioorg Med Chem; 2011 Aug; 19(15):4421-36. PubMed ID: 21752654
[TBL] [Abstract][Full Text] [Related]
20. Microarray-based transcriptional profiling of renieramycin M and jorunnamycin C, isolated from Thai marine organisms.
Charupant K; Suwanborirux K; Daikuhara N; Yokoya M; Ushijima-Sugano R; Kawai T; Owa T; Saito N
Mar Drugs; 2009 Oct; 7(4):483-94. PubMed ID: 20098592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
